St. Johns Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
St. Johns Investment Management's GILD Position: Q3 2018 in Review
St. Johns Investment Management sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 500 shares — an estimated $35K sold.
St. Johns Investment Management first reported a position in GILD in Q3 2014 and held it in 16 quarters. The position peaked at $785K in Q4 2015. 1,527 funds tracked by Wall St. Rank hold GILD as of Q3 2018.
- St. Johns Investment Management reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
- St. Johns Investment Management sold 500 Gilead Sciences shares in Q3 2018, an estimated $35K.
- St. Johns Investment Management first reported a position in Gilead Sciences in Q3 2014 and held it in 16 quarters.
- St. Johns Investment Management's Gilead Sciences position peaked at $785K in Q4 2015.
- 1,527 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.
Based on St. Johns Investment Management's 13F filing for Q3 2018, filed 22 Oct 2018.